pre-ipo
Stage
About
Kite Pharma is a biopharmaceutical company specializing in the development of cancer immunotherapy products based on engineered autologous and allogeneic chimeric antigen receptor (CAR) and T cell receptor (TCR) therapies.
Explore Kite Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.